Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Kevin Balthaser > Profile

Kevin Balthaser

Affiliations

  • Chief Financial Officer at Aclaris Therapeutics Inc. (ACRS), 2025-03-04
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACRS $7.90 9,490 $74,971.00 15,461 2023-09-06 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ACRS $12.63 894 $11,289.52 5,256 2023-03-03 Filing
ACRS $12.29 1,000 $12,289.00 4,650 2023-03-02 Filing